Drug Shortage Report for APO-COLESEVELAM

Last updated on 2024-05-10 History
Report ID 216646
Drug Identification Number 02494051
Brand name APO-COLESEVELAM
Common or Proper name COLESEVELAM
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) COLESEVELAM HYDROCHLORIDE
Strength(s) 625MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 180 BTL
ATC code C10AC
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-01-16
Estimated end date 2024-06-21
Actual end date
Shortage status Actual shortage
Updated date 2024-05-10
Company comments Product on allocation
Health Canada comments
Tier 3 Status Yes
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2024-05-10 French Compare
v15 2024-05-10 English Compare
v14 2024-03-15 French Compare
v13 2024-03-15 English Compare
v12 2024-03-01 French Compare
v11 2024-03-01 English Compare
v10 2024-02-20 English Compare
v9 2024-02-09 French Compare
v8 2024-02-09 English Compare
v7 2024-02-02 French Compare
v6 2024-02-02 English Compare
v5 2024-01-26 French Compare
v4 2024-01-26 English Compare
v3 2024-01-19 French Compare
v2 2024-01-19 English Compare
v1 2024-01-19 English Compare

Showing 1 to 16 of 16